Dec 20 (Reuters) - Microbix Biosystems Inc MBX.TO :
* MICROBIX REPORTS RESULTS FOR FISCAL 2019
* Q4 REVENUE ROSE 6 PERCENT TO C$3.587 MILLION
* QTRLY LOSS PER SHARE $0.001
* MICROBIX BIOSYSTEMS - FOR FISCAL 2020, CO WILL WORK TO
CONTINUE
IMPROVING PERCENTAGE GROSS MARGINS FROM ITS CRITICAL INGREDIENTS
BUSINESS
* MICROBIX BIOSYSTEMS - WORK CONTINUES WITH REGARDS TO
SECURING
PARTNERSHIP AGREEMENT TO ADVANCE MICROBIX'S KINLYTIC UROKINASE
PROJECT
Source text for Eikon: ID:nGNXFZ1wC
Further company coverage: MBX.TO
((Reuters.Briefs@thomsonreuters.com;))